Innovita Biological Technology Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is -47.44% vs -26.49% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is -57.40% vs -34.77% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "108.80",
          "val2": "207.00",
          "chgp": "-47.44%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "39.40",
          "val2": "109.90",
          "chgp": "-64.15%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.10",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "4.30",
          "val2": "3.70",
          "chgp": "16.22%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "40.60",
          "val2": "95.30",
          "chgp": "-57.40%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "362.30%",
          "val2": "488.50%",
          "chgp": "-12.62%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is -32.30% vs 29.81% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -41.47% vs 41.98% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "418.30",
          "val2": "617.90",
          "chgp": "-32.30%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "165.00",
          "val2": "264.20",
          "chgp": "-37.55%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.30",
          "val2": "0.20",
          "chgp": "50.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "5.80",
          "val2": "7.10",
          "chgp": "-18.31%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "144.50",
          "val2": "246.90",
          "chgp": "-41.47%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "308.30%",
          "val2": "379.50%",
          "chgp": "-7.12%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY

Mar'26

Mar'25

Change(%)

Net Sales

108.80

207.00

-47.44%

Operating Profit (PBDIT) excl Other Income

39.40

109.90

-64.15%

Interest

0.10

0.00

Exceptional Items

4.30

3.70

16.22%

Consolidate Net Profit

40.60

95.30

-57.40%

Operating Profit Margin (Excl OI)

362.30%

488.50%

-12.62%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2026 is -47.44% vs -26.49% in Mar 2025

Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is -57.40% vs -34.77% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

418.30

617.90

-32.30%

Operating Profit (PBDIT) excl Other Income

165.00

264.20

-37.55%

Interest

0.30

0.20

50.00%

Exceptional Items

5.80

7.10

-18.31%

Consolidate Net Profit

144.50

246.90

-41.47%

Operating Profit Margin (Excl OI)

308.30%

379.50%

-7.12%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is -32.30% vs 29.81% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -41.47% vs 41.98% in Dec 2024

All Annual Results